SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Advanced Viral Research CP (ADVR)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tracey R. Lanthier Jr. who wrote (1801)12/5/1996 9:18:00 AM
From: Oak Tree   of 2281
 
Tracey- protease inhibitors are more hype than fact. They do not cure aids they just prolong life. This will keep patients alive long eneough to need even more of any other effective products. The sad thing is that all aids drug companies benefit from a new non-curative aids drug. The soup of drugs that are given to aids patients will just get thicker. When ADVR gets FDA approval you can count of ADVR going to $5-10. Until then enjoy the ride up a down.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News